We've all seen impressive demos of prototype brain implants being used by paralyzed patients to interface with computers, but none of those implants have entered general clinical use. Biomedical device company Synchron is close to actually coming to market with its stentrode technology, promising less spectacular results than some of its competitors, but making up for that with ease of use and implant longevity. Synchron's co-founder Tom Oxley talks with IEEE Spectrum senior editor Eliza Strickland about the new tech, and you can read more in our January issue article by Emily Waltz.
.png)
More
Religion & Spirituality
Education
Arts and Design
Health
Fashion & Beauty
Government & Organizations
Kids & family
Music
News & Politics
Science & Medicine
Society & Culture
Sports & Recreation
TV & Film
Technology
Philosophy
Storytelling
Horror and Paranomal
True Crime
Leisure
Travel
Fiction
Crypto
Marketing
History
Comedy
Arts
Games & Hobbies
Business
Motivation